[{"address1": "960 San Antonio Road", "city": "Palo Alto", "state": "CA", "zip": "94303", "country": "United States", "phone": "650 516 4310", "website": "https://www.scilexholding.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is headquartered in Palo Alto, California.", "fullTimeEmployees": 111, "companyOfficers": [{"maxAge": 1, "name": "Dr. Henry H. Ji Ph.D.", "age": 60, "title": "Executive Chairman", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 1261651, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaisim  Shah", "age": 64, "title": "President, CEO & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 1266574, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Suketu D. Desai Ph.D.", "age": 59, "title": "CTO & Senior VP", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven F. Lincoln J.D.", "title": "General Counsel & Chief Compliance Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sumant  Rajendran", "title": "Executive Director of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh K. Khemani", "age": 64, "title": "Senior VP & Chief Commercial Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 456820, "exercisedValue": 0, "unexercisedValue": 3799157}, {"maxAge": 1, "name": "Ms. Gigi  DeGuzman", "title": "Senior Executive Director & Chief of Staff", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Elaine K Chan Pharm.D.", "title": "Executive Director & Head of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.72, "open": 10.7, "dayLow": 10.14, "dayHigh": 11.98, "regularMarketPreviousClose": 10.72, "regularMarketOpen": 10.7, "regularMarketDayLow": 10.14, "regularMarketDayHigh": 11.98, "payoutRatio": 0.0, "beta": 1.195, "forwardPE": -30.666668, "volume": 240399, "regularMarketVolume": 240399, "averageVolume": 153906, "averageVolume10days": 242610, "averageDailyVolume10Day": 242610, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 67543264, "fiftyTwoWeekLow": 3.6, "fiftyTwoWeekHigh": 59.85, "priceToSalesTrailing12Months": 1.3319516, "fiftyDayAverage": 6.1543, "twoHundredDayAverage": 13.726725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 108710576, "profitMargins": -1.4693401, "floatShares": 4990167, "sharesOutstanding": 5647430, "sharesShort": 430140, "sharesShortPriorMonth": 446065, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0783, "heldPercentInsiders": 0.21576999, "heldPercentInstitutions": 0.18551001, "shortRatio": 5.16, "shortPercentOfFloat": 0.1078, "impliedSharesOutstanding": 5647430, "bookValue": -38.498, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -74510000, "trailingEps": -15.27, "forwardEps": -0.39, "lastSplitFactor": "1:35", "lastSplitDate": 1744675200, "enterpriseToRevenue": 2.144, "enterpriseToEbitda": -1.204, "52WeekChange": -0.78775513, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 11.96, "targetHighPrice": 490.0005, "targetLowPrice": 490.0005, "targetMeanPrice": 490.0005, "targetMedianPrice": 490.0005, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 5800000, "totalCashPerShare": 1.056, "ebitda": -90298000, "totalDebt": 48809000, "quickRatio": 0.06, "currentRatio": 0.104, "totalRevenue": 50710000, "revenuePerShare": 8.585, "returnOnAssets": -0.69262004, "grossProfits": 36477000, "freeCashflow": 42758876, "operatingCashflow": 15965000, "revenueGrowth": -0.54, "grossMargins": 0.71933, "ebitdaMargins": -1.78067, "operatingMargins": -5.57514, "financialCurrency": "USD", "symbol": "SCLX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Scilex Holding Company", "longName": "Scilex Holding Company", "postMarketChangePercent": -0.250834, "postMarketPrice": 11.93, "postMarketChange": -0.0299997, "regularMarketChange": 1.24, "regularMarketDayRange": "10.14 - 11.98", "corporateActions": [], "postMarketTime": 1753486657, "regularMarketTime": 1753473600, "exchange": "NCM", "messageBoardId": "finmb_607715156", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 11.5672, "regularMarketPrice": 11.96, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 153906, "fiftyTwoWeekLowChange": 8.360001, "fiftyTwoWeekLowChangePercent": 2.3222225, "fiftyTwoWeekRange": "3.6 - 59.85", "fiftyTwoWeekHighChange": -47.89, "fiftyTwoWeekHighChangePercent": -0.8001671, "fiftyTwoWeekChangePercent": -78.77551, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755028800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -15.27, "epsForward": -0.39, "epsCurrentYear": -3.51, "priceEpsCurrentYear": -3.4074075, "fiftyDayAverageChange": 5.8057, "fiftyDayAverageChangePercent": 0.94335663, "twoHundredDayAverageChange": -1.7667246, "twoHundredDayAverageChangePercent": -0.12870693, "priceToBook": -0.3106655, "sourceInterval": 15, "cryptoTradeable": false, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1614954600000, "displayName": "Scilex Holding", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]